NCT00000646View on ClinicalTrials.gov

Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS

PHASE1CompletedINTERVENTIONAL

Enrollment

54

Participants

Timeline

Start Date

Not specified

Study Completion Date

March 31, 1993

Conditions

HIV Infections

Interventions

DRUG

Pentoxifylline

Trial Locations (2)

02215

Beth Israel Deaconess - East Campus A0102 CRS, Boston

Unknown

Case CRS, Cleveland

Sponsors

Collaborators (1)

Hoechst Marion Roussel

All Listed Sponsors

collaborator

Hoechst Marion Roussel

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH